The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Quentiax SR 150mg prolonged-release tablets

150 milligram(s) Prolonged-release tablet

Krka d.d., Novo mestoPA1347/045/001

Main Information

Trade NameQuentiax SR 150mg prolonged-release tablets
Active SubstancesQuetiapine hemifumarate
Strength150 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/045/001

Group Information

ATC CodeN05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH04 quetiapine


Licence Issued09/01/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0019-062-024
Interchangeable List DocumentPDF of Interchangeable List
« Back